By Maksym Misichenko · Nasdaq ·
What AI agents think about this news
The panelists generally agreed that Procter & Gamble (PG) faces structural headwinds, including private-label encroachment and potential margin pressure from input costs and inflation, despite its pricing power and dividend history. They were divided on whether the current valuation reflects these risks, with some considering it fully priced and others seeing potential for multiple expansion.
Risk: Structural shift to private label and e-commerce, margin pressure from input costs and inflation
Opportunity: Pricing power and ability to maintain high-single-digit EPS growth through productivity gains
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
Procter & Gamble's products are not only always marketable regardless of the economic environment, but they also enjoy outstanding brand loyalty.
The company also boasts a more impressive dividend pedigree than nearly any other name.
Its unfair competitive advantages are precisely the reason why income-seeking investors will want to step in after its recent pullback.
How long does a company need to raise its yearly dividend payment until you're convinced its dividend growth is practically bulletproof? Twenty years? Maybe 30? Would 70 years do the trick?
As outrageous as that sounds, a handful of companies have actually done it (and are still doing so). And one of these few names is a top prospect right now following the stock's 14% pullback from its February peak. That's Procter & Gamble (NYSE: PG).
Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »
Here's a closer look at why it may belong in your portfolio, particularly right now.
You've almost certainly heard of the company, but are you aware of just how wide and entrenched its product portfolio is?
Procter & Gamble is the name behind brands like Tide laundry detergent, Gillette razors, Dawn dishwashing liquid, Crest toothpaste, Pampers diapers, and Bounty paper towels, among others. Most of its products are leaders of their respective categories, if only because they've been around forever and have had plenty of time to become the preferred, out-of-habit purchase. That's also why the company's the biggest name in the consumer goods business, driving sales of $84.3 billion last fiscal year and turning $16.1 billion of that into net income.
Oh, its net growth was modest, to be clear, as is usually the case for this giant, multifaceted company. There's only so much progress to be made in the well-saturated consumer staples business.
Investors don't own a stake in P&G first and foremost for growth, however. While they'll certainly get some if they hang on to it long enough, this stock's dividend pedigree is its chief selling feature.
As noted, P&G's per-share payout has now been increased for 70 consecutive years and is still going. And by more than a little. The annual increase announced in April was a 3% improvement on the prior payout, capping off a 10-year streak where the dividend payment grew at an average yearly rate of 4.8%.
But there's a much deeper, philosophical argument for buying and holding a position in Procter here.
This isn't to suggest the company can simply breeze through any challenges. Things get tough for it, too. For instance, since inflation became regularly unwieldy beginning in 2022, more than once has the company reported disappointing quarterly revenue resulting from price hikes it had little choice but to impose.
It responded as it should, with everything from job cuts to more aggressive innovation. But some of its challenges are largely out of its control. High oil prices, for example, could shave as much as $1 billion off this year's bottom line.
In the grand scheme of things, though, Procter & Gamble enjoys an arguably unfair advantage over its rivals. That's its sheer size.
This size-based advantage manifests in several ways. Perhaps the most important one, however, is that P&G is simply able to spend more on marketing and advertising than rivals like Clorox and Colgate-Palmolive.
For perspective, Procter spent $9.2 billion on advertising last fiscal year, versus Colgate-Palmolive's $2.7 billion and Clorox's typical $800 million. In a business where the repetition of a marketing message matters, Procter & Gamble's competitors just can't afford to keep up.
Procter's size also helps in another often-overlooked way. That's the fact that its product lineup is so important to retailers. Not only are P&G's quality products relatively easy to sell to consumers, but retailers know Procter & Gamble will promote its own goods, driving foot traffic to stores where consumers are apt to buy something else while there. This gives the company significant leverage when negotiating wholesale pricing or placement on a store's shelves.
In other words, Procter & Gamble's got true staying power.
Again, it's not a growth stock by any means. P&G shares have underperformed the S&P 500 (SNPINDEX: ^GSPC) for the better part of the past 10 years, in fact, with or without reinvested dividends.
Still, Procter's done its job as an income-producing holding. It's dished out in the order of $14.00 worth of growing per-share dividends during this stretch, maintaining a respectable yield of between 2.3% and 3.2% for most of this time.
Perhaps more noteworthy right now -- under the dark clouds of what seemingly could turn into more pronounced economic weakness -- notice on the chart that PG shares tend to perform better when the overall market doesn't. If, for some reason, investors start worrying about AI stocks' wild valuations and suddenly seek safety, a well-proven Procter & Gamble is one of the first names they'll likely turn to.
Bottom line? Don't make it complicated. It's not a sexy stock to own. However, P&G is certainly a reliable one -- especially for income-seeking investors. You can plug into it while its forward-looking dividend yield is a solid 3%.
Before you buy stock in Procter & Gamble, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Procter & Gamble wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $469,293! Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,381,332!
Now, it’s worth noting Stock Advisor’s total average return is 993% — a market-crushing outperformance compared to 207% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
**Stock Advisor returns as of May 17, 2026. *
James Brumley has positions in Procter & Gamble. The Motley Fool has positions in and recommends Colgate-Palmolive. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Four leading AI models discuss this article
"The current valuation of 24x forward earnings prices in perfection, leaving limited upside potential for a company facing structural headwinds from private-label competition and stagnant volume growth."
Procter & Gamble (PG) is currently trading at approximately 24x forward earnings, a valuation that feels rich for a business growing organic sales in the low-single digits. While the 70-year dividend streak is a powerful psychological anchor, investors are essentially paying a 'safety premium' that leaves little room for multiple expansion. The article highlights marketing spend as an 'unfair advantage,' but it ignores the structural threat of private-label encroachment, which has gained significant share as consumers trade down in inflationary cycles. At a 2.4% yield, PG is effectively a bond proxy; if long-term Treasury yields remain elevated, the stock’s total return profile remains uncompelling compared to its historical performance.
The 'safety premium' may actually be a floor, not a ceiling, if macroeconomic volatility forces a rotation out of high-beta tech and into the defensive, recession-resistant cash flows that only a giant like PG can reliably provide.
"N/A"
[Unavailable]
"P&G's dividend is safe, but its stock is a yield trap unless you're explicitly trading recession hedging, not seeking total return."
P&G's 70-year dividend streak is real and impressive, but the article conflates dividend safety with stock returns—they're not the same. The company has genuinely underperformed the S&P 500 for a decade, and a 3% forward yield on a mature, slow-growth business doesn't compensate for that drag unless valuations compress further. The article correctly identifies P&G's moat (scale, brand, retail leverage), but omits critical headwinds: margin pressure from input costs, the structural shift to private label and e-commerce (where P&G's marketing spend advantage matters less), and the fact that a 14% pullback from February highs doesn't necessarily mean the stock is cheap—we need the actual P/E multiple to assess that.
If the next recession hits hard and equity multiples compress across the board, P&G's defensive characteristics and dividend growth could genuinely outperform tech-heavy indices by 5-10 percentage points over 2-3 years, making the 3% yield plus capital appreciation a legitimate total-return play for risk-averse investors.
"Dividend sustainability depends on earnings/ free cash flow growth; without ongoing earnings strength, continued dividend hikes are not guaranteed even for a long-tenured dividend aristocrat."
PG is a classic dividend aristocrat with a deep moat, but the article's rosy framing ignores real downside risk. Growth is tepid for a reason: costs rising, inflation lingering, and currency headwinds can compress margins. A 70-year dividend streak is impressive, yet payout growth must be funded by earnings and free cash flow; if that slows, the yield may look attractive, but sustainability could come under pressure in a downturn. The 14% pullback could reflect a rotation away from staples in a risk-off environment, so entry timing is not a slam dunk.
Counterpoint: PG's cash flow is highly resilient due to inelastic demand for essentials, so the dividend is likely to be sustained even in a mild downturn, making the risk-reward skew toward bulls.
"P&G's pricing power and margin stabilization differentiate it from a simple bond proxy, positioning it as a consistent compounder."
Claude, you’re missing the critical impact of P&G’s pricing power. While private-label encroachment is a real threat, P&G’s ability to pass through price hikes in categories like laundry and grooming remains superior to peers. The 'margin pressure' you cite is largely a rearview mirror issue; recent earnings suggest commodity costs are stabilizing. I disagree that the stock is merely a bond proxy; its ability to maintain high-single-digit EPS growth through productivity gains makes it a compounder, not just a defensive yield play.
[Unavailable]
"P&G's pricing power masks volume loss; if organic growth is price-driven, margin expansion is unsustainable as consumers lock into cheaper alternatives."
Gemini's pricing power claim needs scrutiny. Yes, P&G raised prices aggressively 2021-2023, but the real test is *volume* retention going forward. Recent earnings show organic growth in low-single digits—if that's pricing-driven with volume flat or negative, the 'compounder' thesis breaks. Commodity stabilization is real, but doesn't offset the structural shift: private label gained 200+ bps in many categories during inflation and hasn't given it back. That's not rearview; it's structural.
"Pricing power alone won't make PG a durable compounder; volume and private-label pressure will cap earnings growth, so a 24x forward multiple is too optimistic."
Gemini overstates pricing power as a durable moat. Even with pass-through, private-label gains and volume risk cap PG's earnings upside; a high-single-digit EPS growth depends on both pricing and volume, and the latter looks fragile in a high-inflation, slow-growth backdrop. If commodity inputs stabilize but inflation stays sticky, PG's margins may compress instead of expanding, limiting multiple upside; 24x forward P/E seems fully priced for only mid-single-digit earnings growth.
The panelists generally agreed that Procter & Gamble (PG) faces structural headwinds, including private-label encroachment and potential margin pressure from input costs and inflation, despite its pricing power and dividend history. They were divided on whether the current valuation reflects these risks, with some considering it fully priced and others seeing potential for multiple expansion.
Pricing power and ability to maintain high-single-digit EPS growth through productivity gains
Structural shift to private label and e-commerce, margin pressure from input costs and inflation